Cannabis Bioscience International Holdings reported revenue of $0.00B and net income of -$0.00B for the quarter ended Feb 2026, down 25.0% year over year. This income statement covers 14 quarters of results from Nov 2022 through Feb 2026, standardized by Business Quant from the company’s SEC filings.
| Income Statement | Nov2022 | Feb2023 | May2023 | Aug2023 | Nov2023 | Feb2024 | May2024 | Aug2024 | Nov2024 | Feb2025 | May2025 | Aug2025 | Nov2025 | Feb2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue & cost | ||||||||||||||
| Revenue | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cost of RevenueCost of Rev | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Gross Profit | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Operating items | ||||||||||||||
| Research & DevelopmentR&D | 0.00B | 0.00B | 0.00B | 0.00B | 197.00 | 378.00 | 186.00 | 142.00 | 97.00 | 215.00 | 63.00 | 213.00 | 62.00 | 983.00 |
| Selling, General & AdministrativeSG&A | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | -0.00B | 0.00B | 0.00B | 0.00B |
| Other Operating ExpensesOther Opex | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Operating ExpensesOpex | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Operating IncomeOp. Inc | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| EBIT | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Non-operating items | ||||||||||||||
| Non Operating Interest Expenses | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Other Non Operating IncomeOther Non Op Inc. | 99.00 | 0.00B | 0.00B | 0.00B | 101.00 | |||||||||
| Non Operating IncomeNon Op. Inc. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | 0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Net income details | ||||||||||||||
| EBT | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Profit After TaxPAT | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Income from Continuing OperationsIncome (Continuing) | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Consolidated Net IncomeConsol Net Inc. | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Income towards Parent CompanyParent Net Inc | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Net Income towards Common StockholdersNet Income | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Additional items | ||||||||||||||
| EPS (Basic) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS (Diluted) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Shares Outstanding | 8.09B | 7.86B | 9.00B | 10.33B | 10.33B | 10.37B | 10.32B | 10.46B | 10.50B | 10.73B | 10.72B | 11.63B | 11.63B | 11.63B |
| Shares Outstanding (Diluted)Shares Outstanding (Dil.) | 8.09B | 7.86B | 9.00B | 10.33B | 10.33B | 10.37B | 10.32B | 10.46B | 10.50B | 10.73B | 10.72B | 11.63B | 11.63B | 11.63B |
| Shares Outstanding (Entity)Shares Outstanding (Entity.) | 8.85B | 7.86B | 10.06B | 10.33B | 10.33B | 10.43B | 10.43B | 10.56B | 10.51B | 10.93B | 11.63B | 11.63B | 11.63B | 11.63B |
| EBITDA | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B | -0.00B |
| Interest ExpensesInt Expense | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |